Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Tonghe Pharmaceutical: The company's raw materials have been approved by CDE
Tonghe Pharmaceutical Announcement: Recently, it was learned from the “Raw Material and Packaging Registration Information Publicity” platform of the National Medical Products Administration’s Center for Drug Evaluation (CDE) that the company’s submitted raw drug “Tosartan Eltrombopag” has passed CDE approval. The registration number is Y20240000672, the product name is Tosartan Eltrombopag, the company name is Jiangxi Tonghe Pharmaceutical Co., Ltd., located at No. 888 Tiangong Avenue, High-tech Industrial Park, Fengxin, Jiangxi. The product source is domestic production, and the review and approval result is A (approved for use in marketed formulations).